Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 14, 2024
Regulation

Stealth’s advisory committee meeting showcases power of patient voice

Barth syndrome advocates showed how tenacious patients can seize their destiny
BioCentury | Mar 26, 2024
Distillery Therapeutics

An oncolytic circular RNA therapy for adenocarcinomas

BioCentury | Mar 12, 2024
Discovery & Translation

Distillery spotlight: new mitochondrial mechanisms from academia

Correcting mitochondrial dynamics, metabolic control of pathogenic or therapeutic cells emerge among translational innovations in BioCentury’s survey of 2023 publications
BioCentury | Jan 18, 2024
Distillery Therapeutics

Targeting cytochrome c peroxidase activity for Barth Syndrome

BioCentury | Jul 27, 2023
Regulation

Tiny biotech says its troubles make case for ultra-rare FDA pathway

Stealth BioTherapeutics has struggled to get a therapy approved for Barth syndrome
BioCentury | Jun 11, 2022
Discovery & Translation

In vivo B cell engineering to produce anti-HIV antibodies; plus Ovid, Stealth and more

BioCentury’s roundup of translational news
BioCentury | Jun 5, 2021
Targets & Mechanisms

Going beyond genetic medicines for muscular dystrophy

Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones
BioCentury | Oct 11, 2019
Company News

Alexion deal lends late-stage support to Stealth

Items per page:
1 - 10 of 50